These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36074252)

  • 1. "From Where I Stand": using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ).
    Bartlett SJ; Bykerk VP; Schieir O; Valois MF; Pope JE; Boire G; Hitchon C; Hazlewood G; Bessette L; Keystone E; Thorne C; Tin D; Bingham CO;
    Qual Life Res; 2023 May; 32(5):1307-1318. PubMed ID: 36074252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA).
    Barroso N; Woodworth TG; Furst DE; Guillemin F; Fautrel BJ; Borazan N; Kafaja S; Brook J; Elashoff DA; Ranganath VK
    Clin Rheumatol; 2020 Jan; 39(1):189-199. PubMed ID: 31493148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.
    Curtis JR; Yang S; Chen L; Pope JE; Keystone EC; Haraoui B; Boire G; Thorne JC; Tin D; Hitchon CA; Bingham CO; Bykerk VP
    Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1345-53. PubMed ID: 25988705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.
    Bartlett SJ; Barbic SP; Bykerk VP; Choy EH; Alten R; Christensen R; den Broeder A; Fautrel B; Furst DE; Guillemin F; Hewlett S; Leong AL; Lyddiatt A; March L; Montie P; Pohl C; Scholte Voshaar M; Woodworth TG; Bingham CO
    J Rheumatol; 2017 Oct; 44(10):1536-1543. PubMed ID: 28811351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Minimal and Meaningful Change in a Patient-Reported Outcomes Measurement Information System for Rheumatoid Arthritis: Use of Multiple Methods and Perspectives.
    Bartlett SJ; Gutierrez AK; Andersen KM; Bykerk VP; Curtis JR; Haque UJ; Orbai AM; Jones MR; Bingham CO
    Arthritis Care Res (Hoboken); 2022 Apr; 74(4):588-597. PubMed ID: 33166066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
    Pincus T; Swearingen CJ; Bergman M; Yazici Y
    J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meaningful score changes for SF-36v2, FACIT-fatigue, and RASIQ in rheumatoid arthritis.
    Rendas-Baum R; Lin X; Kosinski M; Bjorner JB; Bracher MG; Chen WH
    J Patient Rep Outcomes; 2024 Jan; 8(1):9. PubMed ID: 38252223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis.
    Revicki D; Ganguli A; Kimel M; Roy S; Chen N; Safikhani S; Cifaldi M
    Value Health; 2015 Dec; 18(8):1008-15. PubMed ID: 26686785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of self-report questionnaires for assessing rheumatoid arthritis activity: a cross-sectional study of RAPID3 and RADAI5 and flare detection in 200 patients.
    Bossert M; Prati C; Vidal C; Bongain S; Toussirot E; Wendling D
    Joint Bone Spine; 2012 Jan; 79(1):57-62. PubMed ID: 21550283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quarter of patients time their early rheumatoid arthritis onset differently than physicians.
    Ellingwood L; Kudaeva F; Schieir O; Bartlett SJ; Bessette L; Boire G; Hazlewood GS; Hitchon C; Keystone E; Tin D; Thorne C; Bykerk VP; Pope J;
    RMD Open; 2019; 5(2):e000931. PubMed ID: 31803498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year.
    Kay J; Morgacheva O; Messing SP; Kremer JM; Greenberg JD; Reed GW; Gravallese EM; Furst DE
    Arthritis Res Ther; 2014 Feb; 16(1):R40. PubMed ID: 24485007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds.
    Strand V; Kosinski M; Gnanasakthy A; Mallya U; Mpofu S
    Health Qual Life Outcomes; 2014 Mar; 12():31. PubMed ID: 24597620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials.
    Ward MM; Guthrie LC; Alba MI
    Ann Rheum Dis; 2015 Sep; 74(9):1691-6. PubMed ID: 24794149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.
    Martin WJ; Shim M; Paulus HE; Chaudhari S; Feng J; Elashoff D; Hahn TJ; Ranganath VK;
    J Clin Rheumatol; 2014 Sep; 20(6):301-5. PubMed ID: 25160011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of Successful Rheumatoid Arthritis Flare Management: Clinician-driven Treatment, Home-based Strategies, and Medication Change.
    Mahmoud TG; Huang J; Frits M; Iannaccone C; Bykerk V; Bingham CO; Weinblatt M; Shadick NA
    J Rheumatol; 2020 Mar; 47(3):333-340. PubMed ID: 31203222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire.
    Myasoedova E; De Thurah A; Erpelding ML; Schneeberger EE; Maribo T; Citera G; Davis JM; Matteson EL; Crowson CS; Fautrel B; Guillemin F
    Semin Arthritis Rheum; 2020 Apr; 50(2):261-265. PubMed ID: 31526593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating PROMIS Measures in a Treat-to-Target Approach to Standardize Patient-Centered Treatment of Rheumatoid Arthritis.
    Greene GJ; Beaumont JL; Bacalao EJ; Muftic A; Kaiser K; Eisenstein AR; Mandelin AM; Cella D; Ruderman EM
    J Rheumatol; 2023 Aug; 50(8):1002-1008. PubMed ID: 37127317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Rheumatoid Arthritis Presentation, Treatment, and Outcomes in Aboriginal Patients in Canada: A Canadian Early Arthritis Cohort Study Analysis.
    Nagaraj S; Barnabe C; Schieir O; Pope J; Bartlett SJ; Boire G; Keystone E; Tin D; Haraoui B; Thorne JC; Bykerk VP; Hitchon C;
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1245-1250. PubMed ID: 29125904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group.
    Alten R; Pohl C; Choy EH; Christensen R; Furst DE; Hewlett SE; Leong A; May JE; Sanderson TC; Strand V; Woodworth TG; Bingham CO;
    J Rheumatol; 2011 Aug; 38(8):1745-50. PubMed ID: 21807796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis.
    Kosinski M; Zhao SZ; Dedhiya S; Osterhaus JT; Ware JE
    Arthritis Rheum; 2000 Jul; 43(7):1478-87. PubMed ID: 10902749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.